| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lung Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Small Cell | |||||
| Lung Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Adenocarcinoma | |||||
| Carcinoma | |||||
| Carcinoma, Neuroendocrine | |||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Nerve Tissue | |||||
| Neuroectodermal Tumors | |||||
| Neuroendocrine Tumors | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Thoracic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| amrubicin hydrochloride | |||||
| irinotecan hydrochloride | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Amrubicin | |||||
| Camptothecin | |||||
| Irinotecan | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Phytogenic | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Japan Multinational Trial Organization | |||||
|
